{"title":"MLGCN-Driver: a cancer driver gene identification method based on multi-layer graph convolutional neural network.","authors":"Pi-Jing Wei, Jingxin Zhou, Rui-Fen Cao, Yun Ding, Zhenyu Yue, Chun-Hou Zheng","doi":"10.1186/s12859-025-06260-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The progression of cancer is driven by the accumulation of mutations in driver genes. Many researches promote to identify cancer driver genes. However, most of them ignore the high-order features in the network.</p><p><strong>Result: </strong>In this study, we propose a novel method MLGCN-Driver based on multi-layer graph convolutional neural networks (GCN) to boost driver gene identification. MLGCN-Driver employs multi-layer GCN with initial residual connections and identity mappings to learn biological multi-omics features within biological networks. In addition, node2vec algorithm is used to extract the topological structure features of the biological network, and then the features are fed into another multi-layer GCN for feature learning. Meanwhile, the initial residual connections and identity mappings mitigate the over-smooth of features. Finally, the probability of each gene being a driver gene is calculated based on low-dimensional biological features and topological features.</p><p><strong>Conclusion: </strong>We applied the MLGCN-Driver on pan-cancer dataset and cancer type-specific datasets. Experimental results demonstrate the excellent performance of MLGCN-Driver in terms of the area under the ROC curve (AUC) and the area under the precision-recall curve (AUPRC) when compared with state-of-the-art approaches.</p>","PeriodicalId":8958,"journal":{"name":"BMC Bioinformatics","volume":"26 1","pages":"233"},"PeriodicalIF":3.3000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12482577/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Bioinformatics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s12859-025-06260-8","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The progression of cancer is driven by the accumulation of mutations in driver genes. Many researches promote to identify cancer driver genes. However, most of them ignore the high-order features in the network.
Result: In this study, we propose a novel method MLGCN-Driver based on multi-layer graph convolutional neural networks (GCN) to boost driver gene identification. MLGCN-Driver employs multi-layer GCN with initial residual connections and identity mappings to learn biological multi-omics features within biological networks. In addition, node2vec algorithm is used to extract the topological structure features of the biological network, and then the features are fed into another multi-layer GCN for feature learning. Meanwhile, the initial residual connections and identity mappings mitigate the over-smooth of features. Finally, the probability of each gene being a driver gene is calculated based on low-dimensional biological features and topological features.
Conclusion: We applied the MLGCN-Driver on pan-cancer dataset and cancer type-specific datasets. Experimental results demonstrate the excellent performance of MLGCN-Driver in terms of the area under the ROC curve (AUC) and the area under the precision-recall curve (AUPRC) when compared with state-of-the-art approaches.
期刊介绍:
BMC Bioinformatics is an open access, peer-reviewed journal that considers articles on all aspects of the development, testing and novel application of computational and statistical methods for the modeling and analysis of all kinds of biological data, as well as other areas of computational biology.
BMC Bioinformatics is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We offer an efficient, fair and friendly peer review service, and are committed to publishing all sound science, provided that there is some advance in knowledge presented by the work.